High-efficiency c-Myc-mediated induction of functional hepatoblasts from the human umbilical cord mesenchymal stem cells

• Published in: Stem cell research & therapy Vol. 12; no. 1; pp. 1 - 375
• Main Authors: Deng, Jie, Luo, Kai, Xu, Pengchao, Jiang, Qingyuan, Wang, Yuan, Yao, Yunqi, Chen, Xiaolei, Cheng, Fuyi, Xie, Dan, Deng, Hongxin
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 02.07.2021; BioMed Central; BMC
• Subjects: Animal experimentation; c-Myc; c-Myc protein; Direct reprogramming; Efficiency; Fibroblasts; Hepatoblast-like cells; Hepatocyte nuclear factor 4; Hepatocytes; Human umbilical cord mesenchymal stem cells; Laboratories; Liver; Liver diseases; Maternal & child health; Mesenchymal stem cells; Molecular modelling; Myc protein; Phenotypes; Plasmids; Stem cell transplantation; Stem cells; Tissue engineering; Umbilical cord
• ISSN: 1757-6512; 1757-6512
• DOI: 10.1186/s13287-021-02419-1

Background Direct reprogramming of human fibroblasts to hepatocyte-like cells was proposed to generate large-scale functional hepatocytes demanded by liver tissue engineering. However, the difficulty in obtaining large quantities of human fibroblasts greatly restricted the extensive implementation of this approach. Meanwhile, human umbilical cord mesenchymal stem cells (HUMSCs) are the preferred cell source for HLCs with the advantages of limited ethical concerns, easy accessibility, and propagation in vitro. However, no direct reprogramming protocol for converting HUMSCs to hepatoblast-like cells (HLCs) has been reported. Methods HLCs were successfully generated from HUMSCs by forced expression of FOXA3, HNF1A, and HNF4A (collectively as 3TFs) and c-Myc. In vitro and in vivo functional experiments were conducted to demonstrate the hepatic phenotype, characterization, and function of HUMSC-derived HLCs (HUMSC-iHeps). ChIP-seq and RNA-seq were integrated to reveal the potential molecular mechanisms underlying c-Myc-mediated reprogramming. Results We showed that c-Myc greatly improved the trans-differentiation efficiency for HLCs from HUMSCs, which remained highly efficient in reprogramming fibroblasts into HLCs, suggesting c-Myc could promote direct reprogramming and its potentially widespread applicability for generating large amounts of HLCs in vitro. Mice transplantation experiments further confirmed the therapeutic potential of HUMSC-iHeps by liver function restoration and survival prolongation. Besides, in vivo safety assessment demonstrated the low risk of the tumorigenic potential of HUMSC-iHeps. We found that c-Myc functioned predominantly at an early phase of reprogramming, and we further unraveled the regulatory network altered by c-Myc. Conclusions c-Myc enhanced reprogramming efficiency of HLCs from HUMSCs. A large scale of functional HLCs generated more conveniently from HUMSCs could benefit biomedical studies and applications of liver diseases. Keywords: Hepatoblast-like cells, Human umbilical cord mesenchymal stem cells, c-Myc, Direct reprogramming